Drug companies pay PDUFA user fees (the 1993 Prescription Drug User Fee Act, renewed repeatedly) to speed FDA review, which shows they do not primarily seek to slow the FDA for anti-competitive reasons.
factualpending
Speaker
Richard EpsteinEvidence Quote
“The drug companies will actually pay the FDA a user fee in order to get quicker expedition of the products coming into market”
Created: 10/30/2026, 3:22:16 PM
Your notes
Loading notes...